References
- Higgs DR, Engel JD, Stamatoyannopoulos G. Thalassemia. Lancet. 2012; 379:373-83.10.1016/S0140-6736(11)60283-321908035
- Greenberg PL, Gordeuk V, Issaragrisil S, Siritanaratkul N, Fucharoen S, Ribeiro RC. Major hematologic diseases in the developing world—new aspects of diagnosis and management of thalassemia, malarial anemia, and acute leukemia. Hematology Am Soc Hematol Educ Program. 2001:479-98.11723000
- Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004; 89:1187-93.15477202
- Borgna-Pignatti C, Cappellini MD, De Stefano P, Del Vecchio GC, Forni GL, Gamberini MR, et al. Survival and complications in thalassemia. Ann N Y Acad Sci. 2005; 1054:40-7.10.1196/annals.1345.00616339650
- Di Bartolomeo P, Santarone S, Di Bartolomeo E, Olioso P, Bavaro P, Papalinetti G, et al. Long-term results of survival in patients with thalassemia major treated with bone marrow transplantation. Am J Hematol. 2008; 83:528-30.10.1002/ajh.2117518383328
- Maggio A, Vitrano A, Capra M, Cuccia L, Gagliardotto F, Filosa A, et al. Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies. Blood Cells Mol Dis. 2009; 42:247-51.10.1016/j.bcmd.2009.01.00219233692
- Nakhakes C, Jaruluxananan S, Saengsuda Y, Saengsuda S. Risk factors for osteoporosis and the relationship between osteoporosis and hemoglobin level in adult patients with thalassemia in Rajavithi hospital. Asian Biomed. 2015; 8:169-74.
- Siripunthana S, Sahakitrungruang T, Wacharasindhu S, Sosothikul D, Supornsilchai V. Testicular function in patients with regular blood transfusion for thalassemia major. Asian Biomed. 2015; 8:185-91.
- Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar S, et al. Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood. 2010; 115:1886-92.10.1182/blood-2009-09-24315420032507
- Al-Rimawi HS, Jallad MF, Amarin ZO, Al Sakaan R. Pubertal evaluation of adolescent boys with β-thalassemia major and delayed puberty. Fertil Steril. 2006; 86:886-90.10.1016/j.fertnstert.2006.02.11817027358
- De Sanctis V, Roos M, Gasser T, Fortini M, Raiola G, Galati MC. Impact of long-term iron chelation therapy on growth and endocrine functions in thalassaemia. J Pediatr Endocrinol Metab. 2006; 19:471-80.16759032
- Chern JP, Lin KH, Tsai WY, Wang SC, Lu MY, Lin DT, et al. Hypogonadotropic hypogonadism and hematologic phenotype in patients with transfusion-dependent beta-thalassemia. J Pediatr Hematol Oncol. 2003; 25:880-4.10.1097/00043426-200311000-0001114608198
- Camaschella C, Cappellini MD. Thalassemia intermedia. Haematologica. 1995; 80:58-68.7758995
- Musallam KM, Taher AT, Rachmilewitz EA. β-thalassemia intermedia: a clinical perspective. Cold Spring Harb Perspect Med. 2012; 2:a013482.22762026
- Taher A, Isma’eel H, Cappellini MD. Thalassemia intermedia: revisited. Blood Cells Mol Dis 2006; 37: 12-20.10.1016/j.bcmd.2006.04.00516737833
- Fucharoen S, Winichagoon P. Prevention and control of thalassemia in Asia. Asian Biomed. 2007; 1:1-6.
- Cao A, Kan YW. The prevention of thalassemia. Cold Spring Harb Perspect Med. 2013; 3:a011775.23378598